Results

Total Results: 684 records

Showing results for "nonopioid".

  1. srdr.ahrq.gov/projects/1671/studies/196129
    January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  2. srdr.ahrq.gov/projects/1671/studies/196132
    January 01, 2018 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  3. srdr.ahrq.gov/projects/1671/studies/196111
    January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  4. srdr.ahrq.gov/projects/1671/studies/196119
    January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  5. srdr.ahrq.gov/projects/1671/studies/196182
    January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  6. srdr.ahrq.gov/projects/1671/studies/196168
    January 01, 2019 - What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  7. srdr.ahrq.gov/projects/1671/studies/196176
    What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…
  12. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  15. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  16. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  17. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-e-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - NPP Table E-1. Neuropathic pain study characteristics Author, Year Country Trial Type Quality Rating Type(s) of Pain Demographics Other Population Characteristics N Randomized N Analyzed Intervention Duration (Weeks) Funding Source Hussain, 2021 Pakistan Placebo-controlled Fair NPP (DPN) Age, mean: 45 Female: 0% R…
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…
  20. srdr.ahrq.gov/projects/1671/studies/196180
    What is the comparative effectiveness of nonopioid pharmacologic therapy (e.g. acetaminophen, NSAIDs, … , combination analgesics, muscle relaxants, anti-nausea medications, and cannabis) versus: 1) other nonopioid … How does effectiveness of nonopioid pharmacologic therapy vary depending on: (1) patient demographics … (e.g. age, race, ethnicity, gender); (2) patient medical comorbidities; (3) the type of nonopioid medication … What are the harms of nonopioid pharmacologic therapy versus other nonopioid pharmacologic therapy, or